PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

NCT02067416 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding agent withdrew funding

Conditions

Breast Cancer

Interventions

DRUG: Anthracycline based chemotherapy
DRUG: taxane-based chemotherapy

Sponsor

Jenny C. Chang, MD

Collaborators

[object Object]
[object Object]